RecallDepth
Class II Terminated

Metformin hydrochloride Extended-Release Tablets, 1000 mg, 60-count bottle, RX only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA, NDC 00591-2720-60

Company
Teva Pharmaceuticals Usa, Inc
Recall Initiated
February 22, 2023
Posted
March 15, 2023
Recall Number
D-0441-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
12,044 Bottles
Firm Location
Parsippany, NJ, United States

Reason for Recall

CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

Distribution

CA

Lot / Code Info

Lot #: 1410946A; Exp. 06/2023

More recalls by Teva Pharmaceuticals Usa, Inc

View all recalls by this company →

Other recent Class II Drug recalls